Search

Displaying results 8241 - 8250 of 9117 in total
  1. Drug

    Cenersen

    go.drugbank.com/drugs/DB15455
    Investigational

    Cenersen is under investigation in clinical trial NCT02243124 (A Study of Aezea® (Cenersen) in Transfusion Dependent Anemia Associated With Myelodysplastic Syndrome (MDS)).

  2. Drug

    Urolithin A

    go.drugbank.com/drugs/DB15464
    Experimental

    Urolithin A is a metabolite of ellagic acid. It has been demonstrated to stimulate mitophagy and improve muscle health in old animals and in preclinical models of aging.[A179494]

    Synonyms: Uro-A, Urolithin A
  3. Drug

    Fish liver oil

    go.drugbank.com/drugs/DB15481
    ApprovedWithdrawn

    Mixtures: A+ Zinc TabProducts: Vitamine A 10000 U.I., Vitamine A 10000ui Capsule
  4. Drug

    Cerdulatinib

    go.drugbank.com/drugs/DB15499
    Investigational

    Cerdulatinib is under investigation in clinical trial NCT04021082 (CELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/refractory Peripheral T-cell Lymphoma (PTCL)).

  5. Drug

    Calcium sulfate

    go.drugbank.com/drugs/DB15533
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  6. Drug

    Zelenirstat

    go.drugbank.com/drugs/DB15567
    Investigational

    Zelenirstat (PCLX-001) is a first-in-kind N-Myristoyltransferase (NMT) inhibitor being developed by [Pacylex Pharmaceuticals](https://pacylex.com).

  7. Drug

    Zingerone

    go.drugbank.com/drugs/DB15589
    Experimental

    Zingerone is a pungent component of ginger.

  8. Drug

    beta-Apopicropodophyllin

    go.drugbank.com/drugs/DB15590
    Experimental

    beta-Apopicropodophyllin is a component of the freshwater plant _Micranthemum umbrosum_.

  9. Drug

    Molidustat

    go.drugbank.com/drugs/DB15642
    Investigational

    Molidustat is under investigation in clinical trial NCT03350321 (A Study of Molidustat for Correction of Renal Anemia in Non-dialysis Subjects).

  10. Drug

    Ketodarolutamide

    go.drugbank.com/drugs/DB15647
    Experimental

    Ketodarolutamide, a nonsteroidal antiandrogen (NSAA), is the major active metabolite of [darolutamide].